[Letter: Significance of Toxoplasma infections for public health].
D005132:Eye Manifestations; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis; D007231:Infant, Newborn; D007933:Leucomycins / Q000627:therapeutic use; D011739:Pyrimethamine / Q000009:adverse effects* / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced*; D014125:Toxoplasmosis, Congenital / Q000175:diagnosis* / Q000188:drug therapy
D007075:Immunoglobulin M; D007933:Leucomycins; D013411:Sulfadiazine; D011739:Pyrimethamine
De betekenis van Toxoplasma-infecties voor de volksgezondheid